Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

Rhea-AI Summary

Applied DNA Sciences (NASDAQ: APDN) announced that CEO Dr. James A. Hayward will present at the 2022 Virtual Growth Conference hosted by Maxim Group LLC from March 28-30, 2022. The presentation will be available on-demand during the event. The conference will cover various sectors, including biotech and healthcare, and feature multiple presentations, discussions, and Q&A sessions. Applied DNA is known for its LinearDNA platform utilized in diagnostics and drug development. For more details, visit adnas.com.

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in cell-free, enzymatic DNA production, today announced that CEO Dr. James A. Hayward is invited to present at the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest, on March 28^th - 30^th from 9:00 a.m. - 5:00 p.m. EDT. Dr. Hayward’s presentation will be available on-demand for the duration of the conference via the sign-up link: Sign up here to access the presentation

During the virtual conference, investors will hear from executives from a wide range of sectors, including Biotech, Clean Energy, Electric Vehicles, Financial Services, Fintech & REITs, Gaming & Entertainment, Healthcare, Healthcare IT, Infrastructure, Shipping and Technology/Media/Telecom. The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.

This conference will be live on M-Vest. To attend, sign up to become an M-Vest member: Click Here to Reserve your seat

About Applied DNA Sciences

Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction ("PCR")-based manufacturing platform that allows for the large-scale cell-free production of specific DNA sequences.

The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR T therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies.

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.

Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a high-turnkey solution for population-scale COVID-19 testing. safeCircle is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies that increase testing efficiencies and provide for rapid turn-around-times.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company's common stock is listed on NASDAQ under the ticker symbol 'APDN,' and its publicly traded warrant is listed on OTC under the ticker symbol 'APPDW.'

Applied DNA is a member of the Russell Microcap® Index.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220323005721/en/

Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com

Web: www.adnas.com

Twitter: @APDN

Source: Applied DNA Sciences, Inc.

FAQ

What is Applied DNA Sciences presenting at the Virtual Growth Conference?

Applied DNA Sciences is presenting its innovations and business updates at the 2022 Virtual Growth Conference from March 28-30, 2022.

When is Dr. James A. Hayward's presentation at the Virtual Growth Conference?

Dr. James A. Hayward's presentation will occur during the 2022 Virtual Growth Conference on March 28-30, 2022.

How can I access the presentation by Applied DNA Sciences during the conference?

You can access the presentation by signing up at the M-Vest platform to attend the 2022 Virtual Growth Conference.

What technologies does Applied DNA Sciences focus on?

Applied DNA Sciences focuses on cell-free enzymatic DNA production, diagnostics, and drug development through its LinearDNA platform.

What sectors are represented at the Virtual Growth Conference?

The Virtual Growth Conference features sectors like Biotech, Clean Energy, Healthcare, and Fintech, among others.